Glaxosmithkline 1478,4 GBp +0,73% 

Drugmakers Raise Prices on More Than 750 Drugs in the U.S.

Drugmakers have raised prices on more than 750 brand drugs in the United States so far in 2021, according to data analyzed by 46brooklyn Research.

Stock market rally: how I’d invest £7,000 in UK shares right now

These twin share-price drivers will likely move the stock market much higher before the economic sun shines again, so I’d buy shares like these, right now.

£100 a month to invest? I’d go for a Stocks and Shares ISA in 2021

Using a Stocks and Shares ISA is a great way to maximise returns in 2021. Even £100 invested per month could make a big difference to your nest egg, says this Fool.

GlaxoSmithKline : GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with Plasmodium vivax malaria accepted by Australian Therapeutic Goods Administration

For media and investors only

Issued: London UK; Geneva Switzerland

GSK and Medicines for Malaria Venture announced today that the Australian Therapeutic Goods… | January 8, 2021

Global Active Pharmaceutical Ingredients Markets Report 2020 with Profiles of Actavis, BASF, Cambrex, GlaxoSmithKline and Sun Pharmaceutical Industries

Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) — The “Active Pharmaceutical Ingredients: Global Markets” report has been added to …

My 3 top dividend shares for 2021

I’m looking to invest for income in the coming year and here are my three top choices for dividend shares in 2021.

Global Oncology Precision Medicine Market (2020 to 2030) – Analysis and Forecast

Dublin, Jan. 05, 2021 (GLOBE NEWSWIRE) — The “Global Oncology Precision Medicine Market: Focus on Application Area, Ecosystem Type, Country Data (15 …

Pfizer Introduces New Logo Playing Up Role in Drug Creation

The company is launching its first major rebrand in decades in an effort to highlight its shift from a diversified health care giant to one more focused on creating prescription drugs and vaccines, as it brings out its Covid-19 vaccine with BioNTech.

How to invest in healthcare, a massive market sector that offers unparalleled diversification for portfolios

The size and diversity of the healthcare sector make it a key industry for investors building a diversified portfolio. Stocks are often economy-proof.

New Year’s Resolutions and Vaccine Distributions

New Year’s Resolutions and Vaccine Distributions, Stocks: SNOW,ABNB,DASH,AMZN,NFLX,DASH,ZM,PFE,MRNA,JNJ,AZN, release date:Jan 04, 2021

FTSE 100 bargains: my three best shares to buy a passive income for life

2020 was a disappointing year for the FTSE 100, but I hope for better returns in 2021. I see these three cheap shares as ideal for their passive income.

Worldwide Industry For Respiratory Inhaler Devices To 2025 – Widespread Rise In Chronic Respiratory Diseases Presents Opportunities

DUBLIN, Jan. 4, 2021 /PRNewswire/ — The “Global Respiratory Inhaler Devices Market (2020-2025) by Product, Technology, End-User, Disease Indication and

For Many CIOs, 2020’s Digital Acceleration Was Only the Beginning

Chief information officers in 2020 rushed to build digital capabilities that supported virtual operations, from e-commerce features to expanded workplace-communication tools. Many of those projects, spurred by the pandemic, will help set the pace of business for the year ahead, they say.

Drugmakers Plan to Raise Prices in New Year: Reuters, 3 Axis Advisors

Drugmakers including Pfizer Inc., Sanofi SA, and GlaxoSmithKline Plc plan to raise U.S. prices on more than 300 drugs in the United States on Jan. 1,

Drugmakers To Hike Prices For 2021 As Pandemic, Political Pressure Put Revenues At Risk

Teva Pharmaceuticals Inc hiked prices on 15 drugs, including Austedo, which treats rare neurological disorders, and asthma steroid Qvar, which together grossed more than $650 million in sales in 2019 and saw price hikes of between 5% and 6%., , sanofi, pharmaceutical, pfizer, revenues, drugmaker